EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Assessing Sartorius (XTRA:SRT3) Valuation After The Eveo Cell Therapy Platform Launch
Is It Time To Reassess Sartorius (XTRA:SRT3) After Extended Share Price Weakness?
Ensuring reliable PFAS analysis
Sartorius (XTRA:SRT3) Valuation Check As Recent Weakness Contrasts With Rich P/E And DCF Upside
Kepler Capital Keeps Their Hold Rating on Sartorius (0NIR) | Markets Insider
Sartorius launches next-generation platform to boost efficiency in cell therapy production
RBC Capital Sticks to Their Hold Rating for Sartorius (0NIR) | Markets Insider
Analyzing Sonova (OTCMKTS:SONVY) & Sartorius (OTCMKTS:SARTF) - Markets Daily
Kepler Capital Sticks to Its Hold Rating for Sartorius (0NIR) | Markets Insider
Assessing Sartorius (XTRA:SRT3) Valuation As Viral Vaccine Media Demand Gains Attention
Sartorius News
Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility
Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact
Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors
US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning
Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors
How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026
Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities
Latest news
Show moreIran-Israel Cyber Warfare Escalates: A Deep Dive into Digital Conflict
Buffett Sees Few Market Opportunities, Backs Zero Inflation, and Addresses Gates-Epstein Inquiry
Trump's $400M White House Banquet Hall Project Halted by Federal Judge
Iran's Revolutionary Guard Threatens US Tech & Defense Firms Operating in the Middle East
